Leidos’s New Virtual Biotech Startup ‘ExGloH’ Targets Cancer and Infectious Diseases with Improved T Cell Therapies

Published on :

Leidos’s New Virtual Biotech Startup ‘ExGloH’ Targets Cancer and Infectious Diseases with Improved T Cell Therapies Leidos’s ExGloH Leverages Entrepreneurial Science and Industry-Leading Support Infrastructure to Improve Global Health June 4, 2019 The seed for Leidos’s newest division—and virtual startup biotech—Explorations in Global Health (ExGloH) was planted nearly 20 years ago. In 2000, Leidos secured [….]